Editorial overview: Biopharmaceuticals and the future of the pharmaceutical industry

Current Opinion in Drug Discovery and Development

Volumn 10, Issue 5, 2007, Pages 513-514

  Lowe III, J A ^a   Jones, P ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN INHIBITOR; APTAMER; CETUXIMAB; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ETANERCEPT; G PROTEIN COUPLED RECEPTOR; INFLIXIMAB; MONOCLONAL ANTIBODY; NATALIZUMAB; PEGAPTANIB; PRODRUG; PROTEIN INHIBITOR; RECOMBINANT ERYTHROPOIETIN; SUBSTANCE P ANTAGONIST; TACHYKININ; TGN 1412; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

ALZHEIMER DISEASE; BIOTECHNOLOGY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG SAFETY; DRUG SCREENING; EDITORIAL; HUMAN; MULTIPLE SCLEROSIS; DRUG DESIGN; PHARMACEUTICS;

BIOPHARMACEUTICS; DRUG DESIGN; DRUG INDUSTRY;

EID: 34548411390     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (0)